Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 3,500 shares at $32.87 ($114K) on 2021-02-16, disclosed to the SEC on 2021-02-17.
Open-market sale of $114k PLRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.10 | 1,200 | $39K | 33.7% |
| 2 | $32.87 | 2,100 | $69K | 60.4% |
| 3 | $34.07 | 200 | $7K | 6.0% |
| Total | $32.67 avg | 3,500 | $114K | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |